Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nm23-H1 expression does not predict clinical survival in colorectal cancer patients.
Dusonchet L, Corsale S, Migliavacca M, Calò V, Bazan V, Amato A, Cammareri P, Totaro MS, Agnese V, Cascio S, La Rocca G, Sisto PS, Dardanoni G, Valerio MR, Grassi N, Latteri S, Cajozzo M, Buscemi M, Castorina S, Morello V, Tomasino RM, Gebbia N, Russo A. Dusonchet L, et al. Among authors: gebbia n. Oncol Rep. 2003 Sep-Oct;10(5):1257-63. Oncol Rep. 2003. PMID: 12883690
p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.
Russo A, Migliavacca M, Zanna I, Valerio MR, Latteri MA, Grassi N, Pantuso G, Salerno S, Dardanoni G, Albanese I, La Farina M, Tomasino RM, Gebbia N, Bazan V. Russo A, et al. Among authors: gebbia n. Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1322-31. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12433709
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment.
Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N; TP53-CRC Collaborative Study Group. Russo A, et al. Among authors: gebbia n. J Clin Oncol. 2005 Oct 20;23(30):7518-28. doi: 10.1200/JCO.2005.00.471. Epub 2005 Sep 19. J Clin Oncol. 2005. PMID: 16172461 Review.
Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma.
Bazan V, Zanna I, Migliavacca M, Sanz-Casla MT, Maestro ML, Corsale S, Macaluso M, Dardanoni G, Restivo S, Quintela PL, Bernaldez R, Salerno S, Morello V, Tomasino RM, Gebbia N, Russo A. Bazan V, et al. Among authors: gebbia n. J Cell Physiol. 2002 Sep;192(3):286-93. doi: 10.1002/jcp.10138. J Cell Physiol. 2002. PMID: 12124774
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer.
Calò V, Agnese V, Gargano G, Corsale S, Gregorio V, Cascio S, Cammareri P, Bruno L, Augello C, Gullo A, Sisto PS, Badalamenti G, Valerio MR, Napoli L, Gebbia N, Bazan V, Russo A. Calò V, et al. Among authors: gebbia n. Breast Cancer Res Treat. 2006 Mar;96(1):97-100. doi: 10.1007/s10549-005-9049-z. Epub 2005 Oct 22. Breast Cancer Res Treat. 2006. PMID: 16244786
BRCA1 genetic testing in 106 breast and ovarian cancer families from Southern Italy (Sicily): a mutation analyses.
Russo A, Calò V, Agnese V, Bruno L, Corsale S, Augello C, Gargano G, Barbera F, Cascio S, Intrivici C, Rinaldi G, Gulotta G, Macaluso M, Surmacz E, Giordano A, Gebbia N, Bazan V. Russo A, et al. Among authors: gebbia n. Breast Cancer Res Treat. 2007 Nov;105(3):267-76. doi: 10.1007/s10549-006-9456-9. Epub 2007 Jan 13. Breast Cancer Res Treat. 2007. PMID: 17221156
179 results